Nirupama Sundar's Insider Trades & SAST Disclosures
Nirupama Sundar's most recent trade in Neuland Laboratories Ltd. was a Disposal of 500 Equity Shares done at an average price of Rs. 5375.3 . Disclosure was reported to the exchange on Dec. 5, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Nirupama Sundar in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuland Laboratories | Nirupama Sundar | Employees Immediate Relative | Disposal | 05 Dec 2023 | 500 | 500 (0%) | 0.00% | 5375.3 | 2,687,657 | 04 Dec 2023 04 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Neuland Laboratories | Nirupama Sundar | Employees Immediate Relative | Acquisition | 01 Sep 2022 | 900 | 1,000 (0%) | 0.01% | 1154.5 | 1,039,089 | 17 Aug 2022 25 Aug 2022 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.